Key result
A structured perioperative nursing protocol for Yttrium-90 radioactive microsphere therapy in patients with hepatocellular carcinoma resulted in a 100% treatment success rate and a 73.3% overall complication rate, with no severe adverse events.
Why the study?
To explore perioperative nursing protocols and complication management strategies for patients with hepatocellular carcinoma undergoing Yttrium-90 radioactive microsphere therapy.
Observational (n=15)
No
Standardized perioperative nursing workflows and early-warning systems for complications are essential for enhancing the safety of Y-90 microsphere therapy in HCC patients.
Structured nursing protocols appear feasible for Y-90 HCC therapy; leaves open outcome benefits pending prospective validation.
To explore the perioperative nursing protocols and complication management strategies for hepatocellular carcinoma (HCC) patients undergoing Yttrium-90 (Y-90) radioactive microsphere therapy. Methods: A retrospective analysis was performed on clinical data from 15 HCC patients treated with Y-90 radioactive microspheres at Qilu Hospital of Shandong University between December 2024 and April 2025. A structured, multidisciplinary perioperative nursing protocol was implemented, consisting of: (1) Preoperative multidisciplinary evaluation including nutritional risk screening (NRS-2002), radiation dosimetry assessment, and vascular anatomy verification; (2) Intraoperative coordination with specific steps for patient positioning, vascular access establishment, radiation safety measures, and vital sign monitoring; (3) Postoperative dynamic monitoring of vital signs (every 2 h), puncture site condition, laboratory parameters (at 24 and 72 h), and symptom assessment using NRS for pain; (4) Tiered complication management system based on CTCAE v5.0 grading criteria. All 15 patients completed the treatment successfully. The postoperative complication rate was 73.3% (11/15), with manifestations including abdominal pain (five cases), fatigue (three cases), leukopenia (three cases), thrombocytopenia (two cases), and low-grade fever (one case), all complications resolved with appropriate symptomatic management. No severe adverse events such as radiation-induced liver injury or significant myelosuppression occurred. Standardized perioperative nursing workflows, comprehensive radiation protection protocols, and an early-warning system for complications are essential to enhancing the safety of Y-90 microsphere therapy.
No takes yet. Share an insight, caveat, or question.
Xian Li (2025) conducted an observational in Hepatocellular carcinoma (n=15). Yttrium-90 radioactive microsphere therapy with structured perioperative nursing protocol was evaluated on Postoperative complication rate. A structured perioperative nursing protocol for Yttrium-90 radioactive microsphere therapy in patients with hepatocellular carcinoma resulted in a 100% treatment success rate and a 73.3% overall complication rate, with no severe adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: